|
National Stock Number(NSN): 6505-01-074-7743 (6505010747743, 010747743)
| NIIN: |
01-074-7743 |
Item Name: |
FUROSEMIDE INJECTION |
INC: |
30041
|
| FSC: |
6505
|
Assignment Date: |
Apr-06-1979 |
CRIT: |
N |
IIG: |
30041 |
| ISC: |
5 |
Date Standardized: |
Apr-06-1979 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jul-01-2001 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-480-6901 |
Item Name: |
FUROSEMIDE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Jul-01-2001 |
|
INC: |
30041 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1430 |
54536
|
INTERNATIONAL MEDICATION SYSTEMS, LTD. |
H |
3 |
2 |
4 |
75 |
1 |
D |
|
|
|
|
|
MIN-I-JET SYSTEM |
54536
|
INTERNATIONAL MEDICATION SYSTEMS, LTD. |
H |
5 |
1 |
4 |
75 |
1 |
D |
|
|
|
|
|
NDC00548-1430-00 |
54536
|
INTERNATIONAL MEDICATION SYSTEMS, LTD. |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
P |
U |
1 |
A |
$54.97 |
PG |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
H |
|
P |
U |
1 |
F |
$54.97 |
PG |
|
------- |
Oct-01-2000 |
H |
| DN |
S9M |
Y |
|
P |
U |
1 |
N |
$54.97 |
PG |
|
9L----- |
Dec-01-2000 |
H |
| DS |
S9M |
Y |
|
P |
U |
1 |
D |
$54.97 |
PG |
|
------- |
Dec-01-2000 |
H |
| VA |
JVS |
I |
|
P |
U |
0 |
V |
$0.00 |
PG |
|
------- |
Mar-01-1992 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
AQUEOUS |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
SYRINGE-NEEDLE UNIT |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
4.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| CSGS |
ADMINISTRATION |
INTRAMUSCULAR OR INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
NEEDLE SIZE 21 GAGE BY 1-1/2 IN. |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|